FDA Floats OTC Monograph Overhaul To Be “More Agile”
This article was originally published in The Tan Sheet
Executive Summary
The agency will conduct a public hearing on March 25 and 26 for comments about improving the OTC monograph process, which currently faces “significant challenges.”